Wave Life Company Insiders
WVE Stock | USD 5.08 0.24 4.96% |
About 67% of Wave Life's corporate insiders are selling. The analysis of insiders' sentiment of trading Wave Life Sciences stock suggests that many insiders are alarmed at this time. Wave Life employs about 266 people. The company is managed by 28 executives with a total tenure of roughly 149 years, averaging almost 5.0 years of service per executive, having 9.5 employees per reported executive.
Paul Bolno CEO President CEO, Director |
Gregory Verdine Chairman Independent Chairman of the Board |
Wave Life's Insider Buying Vs Selling
33
Selling | Buying |
Latest Trades
2024-04-03 | Kyle Moran | Disposed 15630 @ 6.17 | View | ||
2023-12-11 | Ra Capital Management, L.P. | Acquired 1000000 @ 5 | View | ||
2023-08-23 | Kyle Moran | Disposed 37062 @ 4.75 | View |
Monitoring Wave Life's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Wave |
Wave Life's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Wave Life's future performance. Based on our forecasts, it is anticipated that Wave will maintain a workforce of about 270 employees by May 2024.Wave Life Management Team Effectiveness
The company has Return on Asset of (0.2017) % which means that on every $100 spent on assets, it lost $0.2017. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (11.1817) %, meaning that it generated no profit with money invested by stockholders. Wave Life's management efficiency ratios could be used to measure how well Wave Life manages its routine affairs as well as how well it operates its assets and liabilities. As of April 25, 2024, Return On Tangible Assets is expected to decline to -0.22. In addition to that, Return On Capital Employed is expected to decline to -0.81. At present, Wave Life's Other Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Fixed Asset Turnover is expected to grow to 3.33, whereas Other Assets are forecasted to decline to about 4.1 M.The current year's Common Stock Shares Outstanding is expected to grow to about 111.4 M, whereas Net Loss is forecasted to decline to (152.9 M).
Wave Life Workforce Comparison
Wave Life Sciences is rated third in number of employees category among related companies. The total workforce of Health Care industry is at this time estimated at about 2,019. Wave Life retains roughly 266 in number of employees claiming about 13% of equities under Health Care industry.
The company has Net Profit Margin of (0.51) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of (0.64) %, which entails that for every $100 of revenue, it lost $0.64. Wave Life Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Wave Life insiders, such as employees or executives, is commonly permitted as long as it does not rely on Wave Life's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Wave Life insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
---|---|---|---|---|---|
2023-09-01 | 8.0 | 8 | 1 | 360,000 | 37,062 |
2023-03-01 | 1.0 | 4 | 4 | 1,583,800 | 59,636 |
2022-06-01 | 1.6 | 8 | 5 | 23,907,364 | 82,817 |
2022-03-01 | 1.0 | 5 | 5 | 1,325,000 | 73,683 |
2021-03-01 | 1.8333 | 11 | 6 | 760,930 | 32,629 |
2020-09-01 | 1.3333 | 12 | 9 | 330,000 | 497,577 |
2020-03-01 | 0.7143 | 5 | 7 | 189,000 | 39,979 |
2019-12-01 | 0.2 | 1 | 5 | 6,000 | 42,039 |
2019-09-01 | 6.0 | 12 | 2 | 190,000 | 3,058 |
2019-03-01 | 0.5833 | 7 | 12 | 430,158 | 121,632 |
2018-09-01 | 1.2 | 12 | 10 | 122,571 | 136,110 |
2018-06-01 | 0.5 | 5 | 10 | 74,496 | 186,523 |
2018-03-01 | 0.9375 | 15 | 16 | 390,166 | 91,596 |
2017-12-01 | 1.5 | 3 | 2 | 424,898 | 3,000 |
2017-09-01 | 2.0 | 6 | 3 | 54,000 | 28,161 |
2017-03-01 | 11.0 | 11 | 1 | 219,000 | 433,825 |
2016-12-01 | 4.5 | 9 | 2 | 96,000 | 24,000 |
2016-09-01 | 2.5 | 5 | 2 | 302,750 | 10,000 |
2016-06-01 | 5.0 | 5 | 1 | 385,600 | 52,000 |
2015-12-01 | 0.4 | 6 | 15 | 3,571,636 | 2,796,670 |
Wave Life Notable Stakeholders
A Wave Life stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Wave Life often face trade-offs trying to please all of them. Wave Life's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Wave Life's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
MD MBA | CEO President | Profile | |
Paul Bolno | President CEO, Director | Profile | |
Gregory Verdine | Independent Chairman of the Board | Profile | |
Roberto Guerciolini | Senior Vice President Head of Early Development | Profile | |
Keith Regnante | CFO and Principal Accounting Officer | Profile | |
Roberto MD | Head of Early Devel. and Sr. VP | Profile | |
Chandra Vargeese | Head of Drug Discovery and Sr. VP | Profile | |
Masaharu Tanaka | Independent Director | Profile | |
Adrian Rawcliffe | Independent Director | Profile | |
Takeshi Wada | Independent Director | Profile | |
Peter Kolchinsky | Independent Director | Profile | |
Ken Takanashi | Corporate Secretary and Director | Profile | |
Christian Henry | Additional Independent Director | Profile | |
Koji Miura | Independent Director | Profile | |
Kyle Moran | Head of Fin. and VP | Profile | |
Christopher Francis | Head of Bus. Devel. and VP | Profile | |
Kate Rausch | Investor Relations | Profile | |
Stephen Lake | VP Devel | Profile | |
Linda JD | Senior Counsel | Profile | |
Michael Panzara | Franchise Lead, Neurology | Profile | |
MBA MD | CEO Pres | Profile | |
Kyle CFA | CFO Officer | Profile | |
AnneMarie LiKwaiCheung | Chief Officer | Profile | |
Sridhar Vaddeboina | Manufacturing Chemistry | Profile | |
HsiuChiung Yang | Senior Medicine | Profile | |
Daryn Lewis | Senior Resources | Profile | |
Graham Morrell | IR Contact Officer | Profile | |
Jonathan Rosin | Chief Officer | Profile |
About Wave Life Management Performance
The success or failure of an entity such as Wave Life Sciences often depends on how effective the management is. Wave Life management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Wave management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Wave management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.21) | (0.22) | |
Return On Capital Employed | (0.77) | (0.81) | |
Return On Assets | (0.21) | (0.22) | |
Return On Equity | (1.21) | (1.27) |
The data published in Wave Life's official financial statements usually reflect Wave Life's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Wave Life Sciences. For example, before you start analyzing numbers published by Wave accountants, it's critical to develop an understanding of what Wave Life's liquidity, profitability, and earnings quality are in the context of the Pharmaceuticals space in which it operates.
Please note, the presentation of Wave Life's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Wave Life's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Wave Life's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Wave Life Sciences. Please utilize our Beneish M Score to check the likelihood of Wave Life's management manipulating its earnings.
Wave Life Workforce Analysis
Traditionally, organizations such as Wave Life use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Wave Life within its industry.Wave Life Manpower Efficiency
Return on Wave Life Manpower
Revenue Per Employee | 426K | |
Revenue Per Executive | 4M | |
Net Loss Per Employee | 216.2K | |
Net Loss Per Executive | 2.1M | |
Working Capital Per Employee | 184K | |
Working Capital Per Executive | 1.7M |
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Wave Life Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Complementary Tools for Wave Stock analysis
When running Wave Life's price analysis, check to measure Wave Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Wave Life is operating at the current time. Most of Wave Life's value examination focuses on studying past and present price action to predict the probability of Wave Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Wave Life's price. Additionally, you may evaluate how the addition of Wave Life to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume |
Is Wave Life's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Wave Life. If investors know Wave will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Wave Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.54) | Revenue Per Share 1.068 | Quarterly Revenue Growth 22.451 | Return On Assets (0.20) | Return On Equity (11.18) |
The market value of Wave Life Sciences is measured differently than its book value, which is the value of Wave that is recorded on the company's balance sheet. Investors also form their own opinion of Wave Life's value that differs from its market value or its book value, called intrinsic value, which is Wave Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Wave Life's market value can be influenced by many factors that don't directly affect Wave Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Wave Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Wave Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Wave Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.